Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gamal Eldein Fathy Abd-Ellatef

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pathology, Research and Practice|October 25, 2024
In silico analysis and comprehensive review of circular-RNA regulatory roles in breast diseases; a step-toward non-coding RNA precisionNadia M Hamdy, Mona G El-Sisi, Sherine M Ibrahim, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 29, 2018
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancerIris C Salaroglio, Elena Gazzano, Ahmad Abdullrahman, et al.
Sub-Cellular Biochemistry|January 1, 2026
An Overview of Targeting Some Cancer Hallmarks with Plant Polyphenols: A Step Toward PrecisionNadia M Hamdy, Amr Amin, Gamal Eldein Fathy Abd-Ellatef, et al.
Toxicology Reports|January 31, 2025
Metabolomics integrated genomics approach: Understanding multidrug resistance phenotype in MCF-7 breast cancer cells exposed to doxorubicin and ABCA1/EGFR/PI3k/PTEN crosstalkMai O Kadry, Gamal Eldein Fathy Abd-Ellatef, Naglaa M Ammar, et al.
Pharmacological Research|November 17, 2021
Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoproteinGamal Eldein Fathy Abd-Ellatef, Elena Gazzano, Ahmed H El-Desoky, et al.
Pharmaceutics|January 30, 2020
Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer CellsGamal-Eldein Fathy Abd-Ellatef, Elena Gazzano, Daniela Chirio, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pathology, Research and Practice|October 25, 2024
In silico analysis and comprehensive review of circular-RNA regulatory roles in breast diseases; a step-toward non-coding RNA precisionNadia M Hamdy, Mona G El-Sisi, Sherine M Ibrahim, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 29, 2018
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancerIris C Salaroglio, Elena Gazzano, Ahmad Abdullrahman, et al.
Sub-Cellular Biochemistry|January 1, 2026
An Overview of Targeting Some Cancer Hallmarks with Plant Polyphenols: A Step Toward PrecisionNadia M Hamdy, Amr Amin, Gamal Eldein Fathy Abd-Ellatef, et al.
Toxicology Reports|January 31, 2025
Metabolomics integrated genomics approach: Understanding multidrug resistance phenotype in MCF-7 breast cancer cells exposed to doxorubicin and ABCA1/EGFR/PI3k/PTEN crosstalkMai O Kadry, Gamal Eldein Fathy Abd-Ellatef, Naglaa M Ammar, et al.
Pharmacological Research|November 17, 2021
Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoproteinGamal Eldein Fathy Abd-Ellatef, Elena Gazzano, Ahmed H El-Desoky, et al.
Pharmaceutics|January 30, 2020
Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer CellsGamal-Eldein Fathy Abd-Ellatef, Elena Gazzano, Daniela Chirio, et al.
Pageof 1